BABESIOSIS

This adverse event was reported 277 times

BABESIOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAFENOQUINE 5 0.0758
1 NATURAL VEGETABLE LAXATIVE 1 0.0244
2 UNCARIA TOMENTOSA 1 0.0082
3 ATOVAQUONE 61 0.0074
4 ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL 1 0.0064
5 ARTEMETHER AND LUMEFANTRINE 1 0.0051
6 INOTUZUMAB OZOGAMICIN 15 0.0050
7 ATOVAQUONE AND PROGUANIL HYDROCHLORIDE 7 0.0033
8 ANDEXANET ALFA 1 0.0014
9 BLINATUMOMAB 15 0.0014
See all drugs enriched for association with BABESIOSIS

BABESIOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimalarial [EPC] 62 0.0059
1 Antiprotozoal [EPC] 61 0.0057
2 CD22-directed Immunoconjugate [EPC] 15 0.0050
3 CD20-directed Cytolytic Antibody [EPC] 116 0.0004
4 Tetracycline-class Drug [EPC] 20 0.0003
5 Human Immunoglobulin G [EPC] 5 0.0002
6 alpha-1 Adrenergic Agonist [EPC] 1 0.0002
7 Antiparasitic [EPC] 1 0.0002
8 Pediculicide [EPC] 1 0.0002
9 Sulfone [EPC] 2 0.0002
See all drug classes enriched for association with BABESIOSIS